tradingkey.logo

BioXcel Therapeutics Announces Database Lock In Serenity At-Home Pivotal Phase 3 Safety Trial For Acute Treatment Of Agitation Associated With Bipolar Disorders Or Schizophrenia

ReutersAug 19, 2025 11:21 AM

- BioXcel Therapeutics Inc BTAI.O:

  • BIOXCEL THERAPEUTICS ANNOUNCES DATABASE LOCK IN SERENITY AT-HOME PIVOTAL PHASE 3 SAFETY TRIAL FOR ACUTE TREATMENT OF AGITATION ASSOCIATED WITH BIPOLAR DISORDERS OR SCHIZOPHRENIA

  • BIOXCEL THERAPEUTICS INC - TOPLINE RESULTS EXPECTED IN AUGUST

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI